<?xml version='1.0' encoding='utf-8'?>
<document id="24520393"><sentence text="P-glycoprotein modulates morphine uptake into the CNS: a role for the non-steroidal anti-inflammatory drug diclofenac."><entity charOffset="25-33" id="DDI-PubMed.24520393.s1.e0" text="morphine" /><entity charOffset="107-117" id="DDI-PubMed.24520393.s1.e1" text="diclofenac" /><pair ddi="false" e1="DDI-PubMed.24520393.s1.e0" e2="DDI-PubMed.24520393.s1.e0" /><pair ddi="false" e1="DDI-PubMed.24520393.s1.e0" e2="DDI-PubMed.24520393.s1.e1" /></sentence><sentence text="Our laboratory has previously demonstrated that peripheral inflammatory pain (PIP), induced by subcutaneous plantar injection of Î»-carrageenan, results in increased expression and activity of the ATP-dependent efflux transporter P-glycoprotein (P-gp) that is endogenously expressed at the blood-brain barrier (BBB)" /><sentence text=" The result of increased P-gp functional expression was a significant reduction in CNS uptake of morphine and, subsequently, reduced morphine analgesic efficacy"><entity charOffset="97-105" id="DDI-PubMed.24520393.s3.e0" text="morphine" /><entity charOffset="133-141" id="DDI-PubMed.24520393.s3.e1" text="morphine" /><pair ddi="false" e1="DDI-PubMed.24520393.s3.e0" e2="DDI-PubMed.24520393.s3.e0" /><pair ddi="false" e1="DDI-PubMed.24520393.s3.e0" e2="DDI-PubMed.24520393.s3.e1" /></sentence><sentence text=" A major concern in the treatment of acute pain/inflammation is the potential for drug-drug interactions resulting from P-gp induction by therapeutic agents co-administered with opioids" /><sentence text=" Such effects on P-gp activity can profoundly modulate CNS distribution of opioid analgesics and alter analgesic efficacy" /><sentence text=" In this study, we examined the ability of diclofenac, a non-steroidal anti-inflammatory drug (NSAID) that is commonly administered in conjunction with the opioids during pain therapy, to alter BBB transport of morphine via P-gp and whether such changes in P-gp morphine transport could alter morphine analgesic efficacy"><entity charOffset="43-53" id="DDI-PubMed.24520393.s6.e0" text="diclofenac" /><entity charOffset="211-219" id="DDI-PubMed.24520393.s6.e1" text="morphine" /><entity charOffset="293-301" id="DDI-PubMed.24520393.s6.e2" text="morphine" /><pair ddi="false" e1="DDI-PubMed.24520393.s6.e0" e2="DDI-PubMed.24520393.s6.e0" /><pair ddi="false" e1="DDI-PubMed.24520393.s6.e0" e2="DDI-PubMed.24520393.s6.e1" /><pair ddi="false" e1="DDI-PubMed.24520393.s6.e0" e2="DDI-PubMed.24520393.s6.e2" /><pair ddi="false" e1="DDI-PubMed.24520393.s6.e1" e2="DDI-PubMed.24520393.s6.e1" /><pair ddi="false" e1="DDI-PubMed.24520393.s6.e1" e2="DDI-PubMed.24520393.s6.e2" /></sentence><sentence text=" Administration of diclofenac reduced paw edema and thermal hyperalgesia in rats subjected to PIP, which is consistent with the known mechanism of action of this NSAID"><entity charOffset="19-29" id="DDI-PubMed.24520393.s7.e0" text="diclofenac" /></sentence><sentence text=" Western blot analysis demonstrated an increase in P-gp expression in rat brain microvessels not only following PIP induction but also after diclofenac treatment alone"><entity charOffset="141-151" id="DDI-PubMed.24520393.s8.e0" text="diclofenac" /></sentence><sentence text=" Additionally, in situ brain perfusion studies showed that both PIP and diclofenac treatment alone increased P-gp efflux activity resulting in decreased morphine brain uptake"><entity charOffset="72-82" id="DDI-PubMed.24520393.s9.e0" text="diclofenac" /><entity charOffset="153-161" id="DDI-PubMed.24520393.s9.e1" text="morphine" /><pair ddi="false" e1="DDI-PubMed.24520393.s9.e0" e2="DDI-PubMed.24520393.s9.e0" /><pair ddi="false" e1="DDI-PubMed.24520393.s9.e0" e2="DDI-PubMed.24520393.s9.e1" /></sentence><sentence text=" Critically, morphine analgesia was significantly reduced in animals pretreated with diclofenac (3 h), as compared to animals administered diclofenac and morphine concurrently"><entity charOffset="13-21" id="DDI-PubMed.24520393.s10.e0" text="morphine" /><entity charOffset="85-95" id="DDI-PubMed.24520393.s10.e1" text="diclofenac" /><entity charOffset="139-149" id="DDI-PubMed.24520393.s10.e2" text="diclofenac" /><entity charOffset="154-162" id="DDI-PubMed.24520393.s10.e3" text="morphine" /><pair ddi="false" e1="DDI-PubMed.24520393.s10.e0" e2="DDI-PubMed.24520393.s10.e0" /><pair ddi="false" e1="DDI-PubMed.24520393.s10.e0" e2="DDI-PubMed.24520393.s10.e1" /><pair ddi="false" e1="DDI-PubMed.24520393.s10.e0" e2="DDI-PubMed.24520393.s10.e2" /><pair ddi="false" e1="DDI-PubMed.24520393.s10.e0" e2="DDI-PubMed.24520393.s10.e3" /><pair ddi="false" e1="DDI-PubMed.24520393.s10.e1" e2="DDI-PubMed.24520393.s10.e1" /><pair ddi="false" e1="DDI-PubMed.24520393.s10.e1" e2="DDI-PubMed.24520393.s10.e2" /><pair ddi="false" e1="DDI-PubMed.24520393.s10.e1" e2="DDI-PubMed.24520393.s10.e3" /><pair ddi="false" e1="DDI-PubMed.24520393.s10.e2" e2="DDI-PubMed.24520393.s10.e2" /><pair ddi="false" e1="DDI-PubMed.24520393.s10.e2" e2="DDI-PubMed.24520393.s10.e3" /></sentence><sentence text=" These novel findings suggest that administration of diclofenac and P-gp substrate opioids during pain pharmacotherapy may result in a clinically significant drug-drug interaction"><entity charOffset="53-63" id="DDI-PubMed.24520393.s11.e0" text="diclofenac" /></sentence><sentence text=" " /></document>